Sign in Pull a receipt

RPRX

Royalty Pharma plc

Healthcare · Biotechnology

$232.45 sample

-2.80 (-1.19%) 1D

Market cap

$699.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-21

Alerts

8

Price$232.45 +2.19% 3M daily closessample

241.78227.47

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21SECForm 144 filed
Oct 12SECForm 144 filed
Oct 06INSInsider buy: Director
Sep 28INSInsider buy: General Counsel
Sep 17SECDEF 14A filed
Sep 10SECDEF 14A filed
Sep 02INSInsider sell: General Counsel
Aug 27INSInsider sell: Chief Executive Officer

Sign up to see the real RPRX record →

Company facts

SEC EDGAR registration

Name: Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +19sample, -100 to +100
Reporting currency: USD

Who is positioning in RPRX

sample

Insiders: 9 insider transactions over 90 days, net selling, $298.1M
Congress: 2 members traded over 90 days
Institutions · 13F: 7 funds hold $7.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.7B +17.1% y/y

Q4 2024Q3 2026

Inventory$10.3B +15.1% y/y

Q4 2024Q3 2026

Accounts receivable$7.7B +8.7% y/y

Q4 2024Q3 2026

Total debt$20.3B +9.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $172.3B -9.9% 3M
Sample peer B: $549.2B +5.3% 3M
Sample peer C: $699.2B +1.5% 3M
Sample peer D: $604.3B +13.2% 3M
Sample peer E: $88.6B +6.9% 3M